Transcend Therapeutics
Clinical trials sponsored by Transcend Therapeutics, explained in plain language.
-
PTSD drug shows promise in Long-Term Follow-Up
Symptom relief CompletedThis study looks at the long-term safety and effectiveness of methylone (TSND-201) for people with PTSD. It follows 44 adults who completed a previous methylone trial for up to 52 weeks. Researchers check PTSD symptoms monthly and offer additional treatment if symptoms return.
Phase: PHASE2 • Sponsor: Transcend Therapeutics • Aim: Symptom relief
Last updated Apr 29, 2026 02:24 UTC
-
Could a party drug ease PTSD? new study tests methylone
Symptom relief CompletedThis study tested whether methylone, a drug similar to MDMA, can safely reduce PTSD symptoms. 79 adults with moderate to severe PTSD who had not improved with other treatments received either methylone or a placebo once a week for 4 weeks. Researchers measured symptom changes usi…
Phase: PHASE1, PHASE2 • Sponsor: Transcend Therapeutics • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC